Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Sutro Biopharma Inc (STRO)

Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Sales 153,730 67,770 61,880 42,720 42,740
Sales Growth +126.84% +9.52% +44.85% -0.05% +11.24%
Net Income -106,790 -119,200 -105,540 -32,130 -55,740
Net Income Growth +10.41% -12.94% -228.48% +42.36% -57.81%
(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Total Assets 470,740 406,940 341,410 394,110 156,370
Total Assets Growth +15.68% +19.19% -13.37% +152.04% -29.92%
Total Liabilities 321,090 189,900 88,840 62,060 58,580
Total Liabilities Growth +69.08% +113.76% +43.15% +5.94% -36.05%
(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Operating Cash Flow -111,620 3,550 -81,680 -67,800 -65,020
Operating Cash Flow Growth -3,244.23% +104.35% -20.47% -4.28% -612.78%
Net Cash Flow 22,010 16,840 -175,740 202,050 -120,340
Change in Net Cash Flow +30.70% +109.58% -186.98% +267.90% -216.52%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar